Monday, June 1, 2015
Transgene Announces Positive New Results Presented at ASCO from Phase 2b TIME Trial with TG4010 Immunotherapy in Non-Small Cell Lung Cancer
… product candidate in non-small cell lung cancer, both in
combination with chemotherapy … prostate cancers.
About non-small cell lung cancer:
Lung cancer is one of the most … this disease.
Current treatments for lung cancer include surgery, chemotherapy,
radiation and …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment